
Paul Yu, Ph.D., M.D.
Associate Professor of Medicine, Brigham and Women's Hospital
Publications View
Inhibition of bone morphogenetic protein signal transduction prevents the medial vascular calcification associated with matrix Gla protein deficiency.
Authors: Authors: Malhotra R, Burke MF, Martyn T, Shakartzi HR, Thayer TE, O'Rourke C, Li P, Derwall M, Spagnolli E, Kolodziej SA, Hoeft K, Mayeur C, Jiramongkolchai P, Kumar R, Buys ES, Yu PB, Bloch KD, Bloch DB.
PLoS One
View full abstract on Pubmed
PLoS One
View full abstract on Pubmed
Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration.
Authors: Authors: Tsugawa D, Oya Y, Masuzaki R, Ray K, Engers DW, Dib M, Do N, Kuramitsu K, Ho K, Frist A, Yu PB, Bloch KD, Lindsley CW, Hopkins CR, Hong CC, Karp SJ.
J Pharmacol Exp Ther
View full abstract on Pubmed
J Pharmacol Exp Ther
View full abstract on Pubmed
Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.
Authors: Authors: Mohedas AH, Wang Y, Sanvitale CE, Canning P, Choi S, Xing X, Bullock AN, Cuny GD, Yu PB.
J Med Chem
View full abstract on Pubmed
J Med Chem
View full abstract on Pubmed
C-terminal domain (CTD) small phosphatase-like 2 modulates the canonical bone morphogenetic protein (BMP) signaling and mesenchymal differentiation via Smad dephosphorylation.
Authors: Authors: Zhao Y, Xiao M, Sun B, Zhang Z, Shen T, Duan X, Yu PB, Feng XH, Lin X.
J Biol Chem
View full abstract on Pubmed
J Biol Chem
View full abstract on Pubmed
HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression.
Authors: Authors: Wu XG, Wang Y, Wu Q, Cheng WH, Liu W, Zhao Y, Mayeur C, Schmidt PJ, Yu PB, Wang F, Xia Y.
Blood
View full abstract on Pubmed
Blood
View full abstract on Pubmed
The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6.
Authors: Authors: Mayeur C, Lohmeyer LK, Leyton P, Kao SM, Pappas AE, Kolodziej SA, Spagnolli E, Yu B, Galdos RL, Yu PB, Peterson RT, Bloch DB, Bloch KD, Steinbicker AU.
Blood
View full abstract on Pubmed
Blood
View full abstract on Pubmed
Constitutively active ALK2 receptor mutants require type II receptor cooperation.
Authors: Authors: Bagarova J, Vonner AJ, Armstrong KA, Börgermann J, Lai CS, Deng DY, Beppu H, Alfano I, Filippakopoulos P, Morrell NW, Bullock AN, Knaus P, Mishina Y, Yu PB.
Mol Cell Biol
View full abstract on Pubmed
Mol Cell Biol
View full abstract on Pubmed
Augmentation of Smad-dependent BMP signaling in neural crest cells causes craniosynostosis in mice.
Authors: Authors: Komatsu Y, Yu PB, Kamiya N, Pan H, Fukuda T, Scott GJ, Ray MK, Yamamura K, Mishina Y.
J Bone Miner Res
View full abstract on Pubmed
J Bone Miner Res
View full abstract on Pubmed
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension.
Authors: Authors: Malhotra R, Paskin-Flerlage S, Zamanian RT, Zimmerman P, Schmidt JW, Deng DY, Southwood M, Spencer R, Lai CS, Parker W, Channick RN, Morrell NW, Elliott CG, Yu PB.
Pulm Circ
View full abstract on Pubmed
Pulm Circ
View full abstract on Pubmed
?Np63a-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells.
Authors: Authors: Balboni AL, Hutchinson JA, DeCastro AJ, Cherukuri P, Liby K, Sporn MB, Schwartz GN, Wells WA, Sempere LF, Yu PB, DiRenzo J.
Cancer Res
View full abstract on Pubmed
Cancer Res
View full abstract on Pubmed